List of Tables
Table 1. Immune Check Point Inhibitors Market Trends
Table 2. Immune Check Point Inhibitors Market Drivers & Opportunity
Table 3. Immune Check Point Inhibitors Market Challenges
Table 4. Immune Check Point Inhibitors Market Restraints
Table 5. Global Immune Check Point Inhibitors Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Immune Check Point Inhibitors Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Immune Check Point Inhibitors Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Immune Check Point Inhibitors Product Type
Table 9. Key Companies Time to Begin Mass Production of Immune Check Point Inhibitors
Table 10. Global Immune Check Point Inhibitors Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Check Point Inhibitors as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Immune Check Point Inhibitors Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Immune Check Point Inhibitors Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Immune Check Point Inhibitors Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Immune Check Point Inhibitors Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Immune Check Point Inhibitors Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Immune Check Point Inhibitors Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Immune Check Point Inhibitors Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Immune Check Point Inhibitors Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Immune Check Point Inhibitors Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Immune Check Point Inhibitors Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Immune Check Point Inhibitors Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Immune Check Point Inhibitors Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Immune Check Point Inhibitors Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Immune Check Point Inhibitors Sales Value by Region (2019-2024) & (%)
Table 27. Global Immune Check Point Inhibitors Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Immune Check Point Inhibitors Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Immune Check Point Inhibitors Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Immune Check Point Inhibitors Sales Value, (2025-2030) & (US$ Million)
Table 31. Bristol-Myers Squibb Company Basic Information List
Table 32. Bristol-Myers Squibb Company Description and Business Overview
Table 33. Bristol-Myers Squibb Company Immune Check Point Inhibitors Products, Services and Solutions
Table 34. Revenue (US$ Million) in Immune Check Point Inhibitors Business of Bristol-Myers Squibb Company (2019-2024)
Table 35. Bristol-Myers Squibb Company Recent Developments
Table 36. AstraZeneca Basic Information List
Table 37. AstraZeneca Description and Business Overview
Table 38. AstraZeneca Immune Check Point Inhibitors Products, Services and Solutions
Table 39. Revenue (US$ Million) in Immune Check Point Inhibitors Business of AstraZeneca (2019-2024)
Table 40. AstraZeneca Recent Developments
Table 41. Merck & Co Basic Information List
Table 42. Merck & Co Description and Business Overview
Table 43. Merck & Co Immune Check Point Inhibitors Products, Services and Solutions
Table 44. Revenue (US$ Million) in Immune Check Point Inhibitors Business of Merck & Co (2019-2024)
Table 45. Merck & Co Recent Developments
Table 46. Pfizer, Inc Basic Information List
Table 47. Pfizer, Inc Description and Business Overview
Table 48. Pfizer, Inc Immune Check Point Inhibitors Products, Services and Solutions
Table 49. Revenue (US$ Million) in Immune Check Point Inhibitors Business of Pfizer, Inc (2019-2024)
Table 50. Pfizer, Inc Recent Developments
Table 51. F. Hoffmann-La Roche Ltd Basic Information List
Table 52. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 53. F. Hoffmann-La Roche Ltd Immune Check Point Inhibitors Products, Services and Solutions
Table 54. Revenue (US$ Million) in Immune Check Point Inhibitors Business of F. Hoffmann-La Roche Ltd (2019-2024)
Table 55. F. Hoffmann-La Roche Ltd Recent Developments
Table 56. Incyte Corporation Basic Information List
Table 57. Incyte Corporation Description and Business Overview
Table 58. Incyte Corporation Immune Check Point Inhibitors Products, Services and Solutions
Table 59. Revenue (US$ Million) in Immune Check Point Inhibitors Business of Incyte Corporation (2019-2024)
Table 60. Incyte Corporation Recent Developments
Table 61. NewLink Genetics Corporation Basic Information List
Table 62. NewLink Genetics Corporation Description and Business Overview
Table 63. NewLink Genetics Corporation Immune Check Point Inhibitors Products, Services and Solutions
Table 64. Revenue (US$ Million) in Immune Check Point Inhibitors Business of NewLink Genetics Corporation (2019-2024)
Table 65. NewLink Genetics Corporation Recent Developments
Table 66. Celldex Therapeutics, Inc Basic Information List
Table 67. Celldex Therapeutics, Inc Description and Business Overview
Table 68. Celldex Therapeutics, Inc Immune Check Point Inhibitors Products, Services and Solutions
Table 69. Revenue (US$ Million) in Immune Check Point Inhibitors Business of Celldex Therapeutics, Inc (2019-2024)
Table 70. Celldex Therapeutics, Inc Recent Developments
Table 71. GlaxoSmithKline Basic Information List
Table 72. GlaxoSmithKline Description and Business Overview
Table 73. GlaxoSmithKline Immune Check Point Inhibitors Products, Services and Solutions
Table 74. Revenue (US$ Million) in Immune Check Point Inhibitors Business of GlaxoSmithKline (2019-2024)
Table 75. GlaxoSmithKline Recent Developments
Table 76. Seattle Genetics, Inc. Basic Information List
Table 77. Seattle Genetics, Inc. Description and Business Overview
Table 78. Seattle Genetics, Inc. Immune Check Point Inhibitors Products, Services and Solutions
Table 79. Revenue (US$ Million) in Immune Check Point Inhibitors Business of Seattle Genetics, Inc. (2019-2024)
Table 80. Seattle Genetics, Inc. Recent Developments
Table 81. BeiGene Ltd Basic Information List
Table 82. BeiGene Ltd Description and Business Overview
Table 83. BeiGene Ltd Immune Check Point Inhibitors Products, Services and Solutions
Table 84. Revenue (US$ Million) in Immune Check Point Inhibitors Business of BeiGene Ltd (2019-2024)
Table 85. BeiGene Ltd Recent Developments
Table 86. Eli Lilly and Company (ARMO Biosciences.) Basic Information List
Table 87. Eli Lilly and Company (ARMO Biosciences.) Description and Business Overview
Table 88. Eli Lilly and Company (ARMO Biosciences.) Immune Check Point Inhibitors Products, Services and Solutions
Table 89. Revenue (US$ Million) in Immune Check Point Inhibitors Business of Eli Lilly and Company (ARMO Biosciences.) (2019-2024)
Table 90. Eli Lilly and Company (ARMO Biosciences.) Recent Developments
Table 91. Shanghai Jhunsi Biosciences Ltd Basic Information List
Table 92. Shanghai Jhunsi Biosciences Ltd Description and Business Overview
Table 93. Shanghai Jhunsi Biosciences Ltd Immune Check Point Inhibitors Products, Services and Solutions
Table 94. Revenue (US$ Million) in Immune Check Point Inhibitors Business of Shanghai Jhunsi Biosciences Ltd (2019-2024)
Table 95. Shanghai Jhunsi Biosciences Ltd Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Immune Check Point Inhibitors Downstream Customers
Table 99. Immune Check Point Inhibitors Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Immune Check Point Inhibitors Product Picture
Figure 2. Global Immune Check Point Inhibitors Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Immune Check Point Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 4. Immune Check Point Inhibitors Report Years Considered
Figure 5. Global Immune Check Point Inhibitors Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Immune Check Point Inhibitors Revenue in 2023
Figure 7. Immune Check Point Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. CLTA-4 Inhibitors Picture
Figure 9. PD-1 & PD-L1 Inhibitor Picture
Figure 10. Global Immune Check Point Inhibitors Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Immune Check Point Inhibitors Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Lung Cancer
Figure 13. Product Picture of Blood Cancer
Figure 14. Product Picture of Renal Cancer
Figure 15. Product Picture of Bladder Cancer
Figure 16. Product Picture of Melanoma
Figure 17. Product Picture of Hodgkin Lymphoma
Figure 18. Global Immune Check Point Inhibitors Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Immune Check Point Inhibitors Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Immune Check Point Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Immune Check Point Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Immune Check Point Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Immune Check Point Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Immune Check Point Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Immune Check Point Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Immune Check Point Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Immune Check Point Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Immune Check Point Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Immune Check Point Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Immune Check Point Inhibitors Sales Value (%), (2019-2030)
Figure 31. United States Immune Check Point Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Immune Check Point Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Immune Check Point Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Immune Check Point Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Immune Check Point Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Immune Check Point Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 37. China Immune Check Point Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Immune Check Point Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 39. China Immune Check Point Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Immune Check Point Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Immune Check Point Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Immune Check Point Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Immune Check Point Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Immune Check Point Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Immune Check Point Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Immune Check Point Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Immune Check Point Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Immune Check Point Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 49. India Immune Check Point Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Immune Check Point Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 51. India Immune Check Point Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 52. Immune Check Point Inhibitors Industrial Chain
Figure 53. Immune Check Point Inhibitors Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
